Project #2. IGF-1 signaling pathway in HIV-1 CMS disorders. A significant number of HIV patients develop cognitive disorders and dementia. It is believed that cellular and viral factors released by the HIV-1 infected cells in the white matter, most notably TNFa , are responsible for neuronal injury seen in AIDS brains. Accordingly, we demonstrated that prolonged exposure of differentiated neurons to TNFoc leads to the retraction of neuronal processes in the absence of neuronal apoptosis. HIV-1 infection can also compromise neuroprotective pathways including the insulin-like growth factor 1 (IGF-1) signaling system. Accordingly, in earlier studies we demonstrated that IGF-1 protects neurons from TNFa-induced retraction of neuronal processes. We have demonstrated that TNFa triggers serine phosphorylation of IRS-1 (pS-IRS-1) at the membrane rafts of differentiated neurons, and that pSIRS- 1 interferes with integrin-mediated cellular responses, which are directly involved in the maintenance of neuronal processes and neuronal outgrowth. These observations led us to hypothesize that in HIV encephalitis degeneration of neuronal processes is caused by TNFa-induced interaction between pS-IRS-1 and neuronal integrins, which leads to detachment and retraction of neuronal processes. This detrimental action of TNFoc is counteracted by IGF-l-mediated tyrosine phosphorylation of IRS-1 (pY-IRS-1), which supports the binding of neuronal processes and facilitates tissue remodeling and neuronal outgrowth. We have addressed this hypothesis by experiments described in three Specific Aims.
In Aim#1. we will analyze density of neuronal processes in the regions of HIV encephalitis (HIVE) differentially affected by the accumulation of TNFoc.
In Aim#2. we will evaluate effects of TNFcc on subcellular localization and phosphorylation status of IRS-1;and will analyze molecular interactions between IRS-1, (31-integrin and ADAMs in primary neuronal cultures from the IGF-IR knockout embryos and from age-matching non-transgenic littermates. Finally, in Aim#3. we will examine effects of IGF-I stimulation on neuronal regeneration and tissue remodeling after TNFa -mediated retraction of neuronal processes in differentiated neurosphere cultures from the IGF-IR knockout embryos and from agematching non-transgenic littermates. The outcome of this project will identify and characterize new molecular events, which affect stability of neuronal processes in the paradigm of HIVE, and possibly other neurological disorders characterized by the accumulation of TNFcc. Understanding the cross interaction between IGF-1 and TNFa signaling pathways will help to develop new IGF-l-based therapeutic approaches against neurological disorders in which retraction/degeneration of neuronal processes is a common event.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS043980-10
Application #
8377379
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
10
Fiscal Year
2012
Total Cost
$296,623
Indirect Cost
$98,875
Name
Temple University
Department
Type
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Sen, Satarupa; Kaminiski, Rafal; Deshmane, Satish et al. (2015) Role of hexokinase-1 in the survival of HIV-1-infected macrophages. Cell Cycle 14:980-9
Wang, Jin Ying; Darbinyan, Armine; White, Martyn K et al. (2014) Involvement of IRS-1 interaction with ADAM10 in the regulation of neurite extension. J Cell Physiol 229:1039-46
Darbinian, Nune; Khalili, Kamel; Amini, Shohreh (2014) Neuroprotective activity of pDING in response to HIV-1 Tat. J Cell Physiol 229:153-61
Wollebo, Hassen S; Woldemichaele, Baheru; White, Martyn K (2013) Lentiviral transduction of neuronal cells. Methods Mol Biol 1078:141-6
Johnson, Edward M; Daniel, Dianne C; Gordon, Jennifer (2013) The pur protein family: genetic and structural features in development and disease. J Cell Physiol 228:930-7
Mishra, Mamata; Del Valle, Luis; Otte, Jessica et al. (2013) Pur-alpha regulates RhoA developmental expression and downstream signaling. J Cell Physiol 228:65-72
Sachdeva, Rakhee; Darbinian, Nune; Khalili, Kamel et al. (2013) DING proteins from phylogenetically different species share high degrees of sequence and structure homology and block transcription of HIV-1 LTR promoter. PLoS One 8:e69623
Bookland, Markus J; Darbinian, Nune; Weaver, Michael et al. (2012) Growth inhibition of malignant glioblastoma by DING protein. J Neurooncol 107:247-56
Darbinian, Nune; Gomberg, Rebeccah; Mullen, Loriann et al. (2011) Suppression of HIV-1 transcriptional elongation by a DING phosphatase. J Cell Biochem 112:225-32
Wilk, Anna; Urbanska, Katarzyna; Yang, Shuo et al. (2011) Insulin-like growth factor-I-forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-?-mediated neuronal damage: implications for human immunodeficiency virus encephalitis. J Neurosci Res 89:183-98

Showing the most recent 10 out of 23 publications